EUVIMEDEUVIMED entdecken
Crossref

K v 1.3-induced hyperpolarization is required for efficient Kaposi’s sarcoma–associated herpesvirus lytic replication

Holli Carden iD, Katherine L Harper iD, Timothy J Mottram iD, Oliver Manners, Katie L Allott, Mark L Dallas iD, David J Hughes iD, Jonathan D Lippiat iD, Jamel Mankouri, Adrian Whitehouse iD

Science Signaling · 2024

DOI: 10.1126/scisignal.adg4124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Holli Carden und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, LS2 9JT Leeds, UK. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Kv1.3 Potassium Channel, Virus Replication, NFATC Transcription Factors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi’s sarcoma–associated herpesvirus (KSHV) is an oncogenic herpesvirus that is linked directly to the development of Kaposi’s sarcoma. KSHV establishes a latent infection in B cells, which can be reactivated to initiate lytic replication, producing infectious virions. Using pharmacological and genetic silencing approaches, we showed that the voltage-gated K + channel K v 1.3 in B cells enhanced KSHV lytic replication. The KSHV replication and transcription activator (RTA) protein increased the abundance of K v 1.3 and led to enhanced K + channel activity and hyperpolarization of the B cell membrane. Enhanced K v 1.3 activity promoted intracellular Ca 2+ influx, leading to the Ca 2+ -driven nuclear localization of KSHV RTA and host nuclear factor of activated T cells (NFAT) proteins and subsequently increased the expression of NFAT1 target genes. KSHV lytic replication and infectious virion production were inhibited by K v 1.3 blockers or silencing. These findings highlight K v 1.3 as a druggable host factor that is key to the successful completion of KSHV lytic replication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanKv1.3 Potassium ChannelVirus ReplicationNFATC Transcription FactorsHumansImmediate-Early ProteinsTrans-ActivatorsB-LymphocytesCalciumSarcoma, Kaposi

Substanzen

Kv1.3 Potassium ChannelNFATC Transcription FactorsImmediate-Early ProteinsTrans-ActivatorsRta protein, Human herpesvirus 8CalciumKCNA3 protein, humanNFATC2 protein, human

Autor:innen und Institutionen

  • School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, LS2 9JT Leeds, UK.
  • School of Pharmacy, University of Reading, RG6 6AP Reading, UK.
  • Biomedical Sciences Research Complex, School of Biology, University of St Andrews, North Haugh, KY16 9ST St Andrews, UK.
  • School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, LS2 9JT Leeds, UK.
  • Department of Biochemistry and Microbiology, Rhodes University, Grahamstown 6140, South Africa.

ORCID-Profile: Holli Carden, Katherine L Harper, Timothy J Mottram, Mark L Dallas, David J Hughes, Jonathan D Lippiat, Adrian Whitehouse

Zitieren

APA

Carden, H., Harper, K. L., Mottram, T. J., Manners, O., Allott, K. L., Dallas, M. L., Hughes, D. J., Lippiat, J. D., Mankouri, J., & Whitehouse, A. (2024). K v 1.3-induced hyperpolarization is required for efficient Kaposi’s sarcoma–associated herpesvirus lytic replication. Science Signaling. https://doi.org/10.1126/scisignal.adg4124

Vancouver

Carden H, Harper KL, Mottram TJ, Manners O, Allott KL, Dallas ML, et al. K v 1.3-induced hyperpolarization is required for efficient Kaposi’s sarcoma–associated herpesvirus lytic replication. Science Signaling. 2024. doi:10.1126/scisignal.adg4124

BibTeX
@article{Carden2024,
  author = {Carden, Holli and Harper, Katherine L and Mottram, Timothy J and Manners, Oliver and Allott, Katie L and Dallas, Mark L and Hughes, David J and Lippiat, Jonathan D and Mankouri, Jamel and Whitehouse, Adrian},
  title = {K v 1.3-induced hyperpolarization is required for efficient Kaposi’s sarcoma–associated herpesvirus lytic replication},
  journal = {Science Signaling},
  year = {2024},
  doi = {10.1126/scisignal.adg4124}
}
Kostenlos starten →